Tetanus Survey 2024 (1) prevention-treatment considerations

Effect of ascorbic acid in the treatment of tetanus. Bangladesh Med Res Counc Bull 1984 Jun

The effect of daily intravenous administration of 1000 mg ascorbic acid (AA) in tetanus patients aged 1-30 years was studied. In the age group of 1-12 years, 31 patients were treated with AA as additional to antitetanus serum, sedatives and antibiotics. It was found that none of the patients died who received AA along with the conventional antitetanus therapy. On the other hand, 74.2 per cent of the tetanus patients who received the conventional antitetanus therapy without AA (control group) were succumbed to the infection. In the other age group of 13-30 years, there were 27 and 38 patients in the treatment and control groups respectively. The mortality in the AA and control groups were 37 percent and 67.8 percent respectively. These results suggest that AA might play an important role in reducing the mortality of tetanus. This was supported by the fact that AA was found to mitigate the toxic effects of strychnine producing tetanus like condition in young chicks in the present study.

These results from 1984 showed amazing benefit of vitamin C (ascorbic acid) in the treatment of active tetanus; the dose administered was a very modest 1,000 mg of vitamin C. As such, if the so-called "medical profession" truly followed the science, then this 1) should have become the standard of care, and/or 2) additional studies should have been performed to optimize nutritional treatment of these patients, notably rather than relying solely on drugs and vaccines when this impressively safe and effective treatment is available.

Recent Discoveries in the Treatment of Lockjaw with Vitamin C and Tolserol. Tri-State Medical Journal 1954 July

Benefits of vitamin C in the treatment of tetanus reported by Dr Klenner (cited below) are consistent with the controlled case series published as "Effect of ascorbic acid in the treatment of tetanus" Bangladesh Med Res Counc Bull. 1984 Jun;10(1):24-8. Dr. Fred R. Klenner, Reidsville, N.C. Recent Discoveries in the Treatment of Lockjaw with Vitamin C and Tolserol. Tri-State Medical Journal, July 1954, Vol. 2, No. 2, pp. 7–11

Antiphospholipid Syndrome Following a Diphtheria-Tetanus Vaccination. Isr Med Assoc J 2010; 12: 638–639

Note that the authors make the mistake of communicating "statistical insignificance" as if this were equivalent to clinical insignificance. Such as interpretation would be clearly indicative of (intentional) ignorance and potential misrepresentation in service of the vaccine paradigm.